BPC-157 / TB-500 Wolverine

BPC-157 / TB-500 Wolverine This catalog entry is a two-peptide blend labeled BPC-157 / TB-500 with one 10 mg vial amount. The artwork gives no per-component mass, molar ratio, salt forms, sequence confirmation, excipients, or lot-matched testing. Evidence on either component—or on full-length thymosin beta-4—does not establish the safety or efficacy of this exact blend. FDA's 2026 BPC-157 briefing describes one FAERS report involving a different research-labeled BPC-157/TB-500 product in which diffuse hyperpigmentation and gingival darkening recurred on rechallenge; FDA considered a product association likely but could not assign causality to either peptide. That individual report neither establishes a risk rate nor transfers identity or quality findings to this vial.